Hitachi, Toshiba, Miraca to set up plant for antigen test kits


2/2
© Reuters. FILE PHOTO: Hitachi logos are seen on Electric Power Development Co. Oma Nuclear Power Station under construction in Oma town

2/2

TOKYO (Reuters) – Japanese industrial conglomerates Hitachi Ltd (T:) and Toshiba Corp (T:), and Miraca Holdings (T:) subsidiary Fujirebio will jointly set up a plant in northern Japan to produce antigen coronavirus testing kits, the three companies said on Friday.

The new plant, to be operating by December, will help boost production of Fujirebio’s testing kits, which received government approval in May, the companies said.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





READ SOURCE

READ  U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.20%

LEAVE A REPLY

Please enter your comment!
Please enter your name here